語系: 繁體中文
說明(常見問題)
登入

Cancer drug discovery and development

Titles

cancer chemoprevention.
cancer chemoprevention.
molecular targeting in oncology
molecular targeting in oncology
cancer proteomics
cancer proteomics
antiangiogenic agents in cancer therapy
antiangiogenic agents in cancer therapy
checkpoint responses in cancer therapy
checkpoint responses in cancer therapy
egfr signaling networks in cancer th...
egfr signaling networks in cancer therapy
hormone therapy in breast and prosta...
hormone therapy in breast and prostate cancer
death receptors in cancer therapy
death receptors in cancer therapy
combination cancer therapy
combination cancer therapy
camptothecins in cancer therapy
camptothecins in cancer therapy
bone metastasis
bone metastasis
oncogenomics handbook
oncogenomics handbook
bladder tumors
bladder tumors
tumor models in cancer research
tumor models in cancer research
principles of anticancer drug develo...
principles of anticancer drug development
checkpoint controls and targets in c...
checkpoint controls and targets in cancer therapy
transforming growth factor-[beta] in...
transforming growth factor-[beta] in cancer therapy.
transforming growth factor-[beta] in...
transforming growth factor-[beta] in cancer therapy.
cns cancer
cns cancer
natural killer t cells
natural killer t cells
insulin-like growth factors and cancer
insulin-like growth factors and cancer
dna topoisomerases and cancer
dna topoisomerases and cancer
bioinformatics in cancer and cancer ...
bioinformatics in cancer and cancer therapy
supportive care in cancer therapy
supportive care in cancer therapy
telomeres and telomerase in cancer
telomeres and telomerase in cancer
stem cells and cancer
stem cells and cancer
hypoxia and cancer
hypoxia and cancer
tumor metabolome targeting and drug ...
tumor metabolome targeting and drug development
braf targets in melanoma
braf targets in melanoma
developments in t cell based cancer ...
developments in t cell based cancer immunotherapies
natural products and cancer drug dis...
natural products and cancer drug discovery
advances in dna repair in cancer therapy
advances in dna repair in cancer therapy
antibody-drug conjugates and immunot...
antibody-drug conjugates and immunotoxins
non-hodgkin lymphoma
non-hodgkin lymphoma
pi3k-mtor in cancer and cancer therapy
pi3k-mtor in cancer and cancer therapy
stat inhibitors in cancer
stat inhibitors in cancer
liquid biopsies in solid tumors
liquid biopsies in solid tumors
tumor dormancy and recurrence
tumor dormancy and recurrence
dna and histone methylation as cance...
dna and histone methylation as cancer targets
targeting the dna damage response fo...
targeting the dna damage response for anti-cancer therapy
innovations for next-generation anti...
innovations for next-generation antibody-drug conjugates
increasing the therapeutic ratio of ...
increasing the therapeutic ratio of radiotherapy
ex vivo engineering of the tumor mic...
ex vivo engineering of the tumor microenvironment
developments in t cell based cancer ...
developments in t cell based cancer immunotherapies
parp inhibitors for cancer therapy
parp inhibitors for cancer therapy
braf targets in melanoma
braf targets in melanoma
stat inhibitors in cancer
stat inhibitors in cancer
pi3k-mtor in cancer and cancer therapy
pi3k-mtor in cancer and cancer therapy
targeting the dna damage response fo...
targeting the dna damage response for anti-cancer therapy
innovations for next-generation anti...
innovations for next-generation antibody-drug conjugates
tumor organoids
tumor organoids
unfolded protein response in cancer
unfolded protein response in cancer
estrogen receptor and breast cancer
estrogen receptor and breast cancer
molecular targeted radiosensitizers
molecular targeted radiosensitizers
 
 
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入